Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DSE |
| Upstream (Parents) |
|---|
| (<<) LY96 → DSE |
| (<<) C3AR1 → DSE |
| (<<) CD86 → DSE |
| (<<) C1orf54 → DSE |
| Downstream (Children) |
|---|
| DSE → SP2 (>>) |
| DSE → EPB41L3 (>>) |
| DSE → FAM49A (>>) |
| DSE → P2RX7 (>>) |
| DSE → TNFSF8 (>>) |
| DSE → IRAK3 (>>) |
| DSE → KCTD12 (>>) |
| DSE → BTG3 (>>) |
| DSE → EHMT2 (>>) |
| DSE → CH25H (>>) |
| DSE → ZEB2 (>>) |
| DSE → TRIB2 (>>) |
| DSE → FOXA2 (>>) |
| DSE → THBD (>>) |
| DSE → ARMCX1 (>>) |
| DSE → TRPS1 (>>) |
| DSE → MSN (>>) |
| DSE → C1orf54 (>>) |
| DSE → TSPYL5 (>>) |
